Pharmaceutical Industry
Drug industry treads carefully after stunning RFK Jr. nomination
Pharma still ‘falling short’ in providing access to low- and middle-income countries, analysis finds
With RFK Jr. looming as health secretary, pharma execs try to project stability
RFK Jr. Is a Whacked-Out Crank, but He Is Right About the Pharmaceutical Industry
Despite fears over RFK Jr. pick, industry should focus more on FDA job: analyst
India's pharma industry faces slowdown in licensing and technology transfers, says report
Pharma stocks fall as Trump picks vaccine skeptic Robert F. Kennedy Jr. for US health job
Neurology patient groups call out pharma for inadequate investment in treating disease
Drugs Licensed
Ohio State licenses cancer drug with 'tremendous potential' invented at the James
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Drugmakers and pharmacists battle over who gets to make obesity drugs
FDA weighs in on diet drug shortage, creating more confusion about compounding
Drugs Patents
Pharmaceutical Patents: Benefits and Challenges
What Will The Incoming Trump Administration Mean For Drug Patents?
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Addressing Patent Hurdles, Payer Barriers, and Interchangeability
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
With patent settlement, BeiGene defends blockbuster Brukinsa from MSN's generic threat until 2037
How a Second Trump Presidency Could Shape IP
New ANDA Cases - Federal District Court Cases That Are Filed Pursuant to the Hatch-Waxman Act
Drugs Generics
Trump's tariffs could raise the cost of generic drugs in the U.S.
Donald Trump's proposed tariffs could significantly impact cost of generic drugs in US
Generic drugs ‘safe and effective’
Walgreens Gets Nod for $100 Million Generic Drug Pricing Deal
Elite receives FDA OK for generic Vyvanse
'We have a generic drugs-first policy' says Dzulkefly
Low awareness of generic drugs in AP: Minister Satya Kumar
FDA approves generic florfenicol drug for certain freshwater fish
FDA Food and Drug Administration
Trump's FDA Pick Is MedPage Today's Former Top Editor
FDA launches communications pilot to enhance medical device recall programme
Pharmaceutical Companies
Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Investing in Pharma Stocks? Check These 3 Things First
Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
Dr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment
Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
Meet Hyderabad's richest person, who runs a multi-crore pharma company and has a staggering net worth of Rs 81,000 Crore. Find out who it is
Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?
Six Pharmaceutical Companies Sign MoUs with Telangana Government for Pharma City Investment